X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Fabry Disease Treatment Companies

This report lists the top Fabry Disease Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Fabry Disease Treatment industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Fabry Disease Treatment Top Companies

  1. Sanofi

  2. Takeda Pharmaceuticals

  3. Amicus Therapeutics

  4. ISU ABXIS

  5. JCR Pharmaceuticals

*Disclaimer: Top companies sorted in no particular order

Fabry Disease Treatment Market Major Players

Fabry Disease Treatment Market Concentration

Fabry Disease Treatment  Market Concentration

Fabry Disease Treatment Company List

                          • Sanofi (Genzyme Corporation)

                          • Takeda Pharmaceutical Company Limited

                          • Amicus Therapeutics, Inc

                          • ISU ABXIS

                          • JCR Pharmaceuticals Co., Ltd.

                          • Protalix BioTherapeutics

                          • Chiesi Farmaceutici S.p.A.

                          • Freeline Therapeutics Holdings PLC

                          • Yuhan Corporation

                          • M6P Therapeutics


                      Specific to Fabry Disease Treatment Market
                      Need More Details On Market Players And Competitors?
                      Download PDF

                      Fabry Disease Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)